148
Participants
Start Date
December 6, 2024
Primary Completion Date
September 30, 2028
Study Completion Date
March 31, 2029
GlyNAC (combination of glycine and n-acetylcysteine)
GlyNAC 200 mg/kg/day (100mg glycine and 100mg N-acetyl-cysteine) will be administered orally in two divided doses each day for four weeks prior to TKA and six weeks postoperatively. The preparation will be a commercially available product of 1:1 ratio of glycine and N-acetyl-cysteine.
Placebo
Placebo (alanine) 200 mg/kg/day will be administered orally in two divided doses each day for four weeks prior to TKA and six weeks postoperatively.
RECRUITING
Vanderbilt University Medical Center, Nashville
National Institute on Aging (NIA)
NIH
Vanderbilt University Medical Center
OTHER